Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the bioavailability (the extent to which a medication
becomes available to the body) of subcutaneously (under the skin using a needle) administered
sirukumab and to compare the pharmacokinetics of sirukumab administered subcutaneously using
a pre-filled syringe fitted with the UltraSafe Passive™ Delivery system (PFS-U) with the
SmartJect™ Autoinjector (PFS-AI) in healthy male participants.